In endometrial cancer, NAMPT expression is shown to be relatively higher in endometrial carcinoma patient tissues when compared to normal tissues and that high NAMPT levels lead to poor survival outcomes [113]. This evidence concerns the gene NAMPT and endometrial cancer.